Susquehanna International Group
TTNP

Susquehanna International Group’s Titan Pharmaceuticals TTNP Stock Holding History

Susquehanna International Group’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-920
Closed -$48K – 13594
2021
Q2 		$48K Sell
920
-5,420
-85% -$271K ﹤0.01% 12312
2021
Q1 		$378K Buy
6,340
+5,635
+799% +$373K ﹤0.01% 10114
2020
Q4 		$46K Buy
+705
New +$55.7K ﹤0.01% 10769
2016
Q4 		– Sell
-5
Closed -$113K – 10177
2016
Q3 		$113K Sell
5
-8
-62% -$155K ﹤0.01% 7892
2016
Q2 		$253K Buy
13
+10
+333% +$213K ﹤0.01% 7237
2016
Q1 		$59K Buy
+3
New +$40K ﹤0.01% 8621

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Susquehanna International Group's TTNP Position: Q1 2024 in Review

Susquehanna International Group sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 980 shares — an estimated $8.08K sold.

Susquehanna International Group first reported a position in TTNP in Q3 2016 and held it in 13 quarters. The position peaked at $203K in Q4 2016. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.

  • Susquehanna International Group reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 980 Titan Pharmaceuticals shares in Q1 2024, an estimated $8.08K.
  • Susquehanna International Group first reported a position in Titan Pharmaceuticals in Q3 2016 and held it in 13 quarters.
  • Susquehanna International Group's Titan Pharmaceuticals position peaked at $203K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.